You can find the annual or quarterly income statement of Sensei Biotherapeutics Inc here for insights into the performance and operational efficiency of Sensei Biotherapeutics Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

Operating expenses

-37.99%4.85M

-33.14%5.21M

-16.68%7.27M

-10.06%7.32M

1.11%7.82M

-23.48%7.79M

-20.69%8.73M

-37.60%8.14M

-44.50%7.74M

-4.99%10.18M

-11.84%11.01M

38.62%13.05M

35.14%13.94M

9.48%10.71M

56.69%12.49M

85.40%9.41M

92.32%10.32M

134.68%9.78M

94.22%7.97M

49.02%5.08M

--5.36M

--4.17M

--4.10M

--3.41M

R&D expenses

-45.31%2.54M

-44.74%2.53M

-24.24%3.73M

-0.09%4.49M

21.45%4.64M

-4.18%4.58M

-5.51%4.92M

-38.83%4.49M

-58.45%3.82M

-25.17%4.78M

-30.19%5.20M

23.32%7.34M

42.64%9.19M

8.39%6.39M

121.55%7.46M

133.02%5.96M

80.17%6.44M

106.37%5.90M

53.30%3.37M

5.40%2.56M

--3.58M

--2.86M

--2.19M

--2.42M

Depreciation, depletion, and amortization

-89.76%34.00K

-88.72%37.00K

-89.73%34.00K

6.15%380.00K

0.00%332.00K

-1.20%328.00K

-7.54%331.00K

1.99%358.00K

-2.92%332.00K

3.75%332.00K

7.19%358.00K

6.69%351.00K

151.47%342.00K

162.30%320.00K

240.82%334.00K

370.00%329.00K

112.50%136.00K

134.62%122.00K

326.09%98.00K

204.35%70.00K

--64.00K

--52.00K

--23.00K

Operating profit

37.99%-4.85M

33.14%-5.21M

16.68%-7.27M

10.06%-7.32M

-1.11%-7.82M

23.48%-7.79M

20.69%-8.73M

37.60%-8.14M

44.50%-7.74M

4.99%-10.18M

11.84%-11.01M

-38.62%-13.05M

-35.14%-13.94M

-9.48%-10.71M

-56.69%-12.49M

-85.40%-9.41M

-92.32%-10.32M

-134.68%-9.78M

-94.22%-7.97M

-49.02%-5.08M

---5.36M

---4.17M

---4.10M

---3.41M

Net non-operating interest income (expenses)

Non-operating interest income

-51.10%289.00K

-52.02%321.00K

-47.27%405.00K

-36.80%522.00K

-32.61%591.00K

-29.73%669.00K

-20.74%768.00K

1.35%826.00K

58.59%877.00K

172.78%952.00K

212.58%969.00K

144.01%815.00K

98.92%553.00K

85.64%349.00K

--310.00K

--334.00K

--278.00K

--188.00K

----

--0.00

----

Non-operating interest expense

-71.43%6.00K

-58.33%10.00K

-53.57%13.00K

-45.16%17.00K

-36.36%21.00K

-36.84%24.00K

-33.33%28.00K

--31.00K

-31.25%33.00K

-77.91%38.00K

-82.72%42.00K

----

-77.57%48.00K

17.01%172.00K

8000.00%243.00K

466.67%306.00K

7033.33%214.00K

4800.00%147.00K

-99.82%3.00K

-96.13%54.00K

--3.00K

--1.63M

--1.40M

Gains from sale of securities

----

--0.00

--15.00K

----

Special income (expenses)

----

--0.00

---951.00K

--0.00

100.00%0.00

--0.00

---200.00K

--0.00

-100.00%0.00

----

--0.00

--567.00K

100.00%0.00

-100.00%0.00

100.00%0.00

--0.00

---738.00K

--1.04M

---1.90M

- Gains from disposal of fixed assets

---1.00K

---40.00K

--20.00K

--0.00

100.00%0.00

-100.00%0.00

---6.00K

---191.00K

---105.00K

89.47%36.00K

----

100.00%0.00

----

--19.00K

--0.00

---28.00K

----

Other non-operating income (expenses)

--0.00

---1.00K

0.00%-2.00K

98.51%-1.00K

100.00%0.00

-100.00%0.00

-100.96%-2.00K

-91.43%-67.00K

-1225.00%-225.00K

--68.00K

--209.00K

---35.00K

--20.00K

----

--0.00

----

--0.00

----

--0.00

Income before tax

37.01%-4.57M

30.89%-4.94M

14.11%-6.86M

-4.80%-7.77M

-1.81%-7.25M

23.91%-7.14M

21.47%-7.99M

39.39%-7.41M

46.90%-7.12M

10.91%-9.39M

17.96%-10.18M

-30.60%-12.23M

-38.52%-13.42M

-7.82%-10.54M

-55.61%-12.40M

-82.54%-9.37M

-80.45%-9.69M

-99.00%-9.77M

-69.91%-7.97M

23.48%-5.13M

---5.37M

---4.91M

---4.69M

---6.71M

Income tax

----

--0.00

---14.37M

----

Income after tax

37.01%-4.57M

30.89%-4.94M

14.11%-6.86M

-4.80%-7.77M

-1.81%-7.25M

23.91%-7.14M

21.47%-7.99M

39.39%-7.41M

46.90%-7.12M

10.91%-9.39M

17.96%-10.18M

-30.60%-12.23M

-38.52%-13.42M

-7.82%-10.54M

-55.61%-12.40M

-82.54%-9.37M

-80.45%-9.69M

-99.00%-9.77M

-69.91%-7.97M

23.48%-5.13M

---5.37M

---4.91M

---4.69M

---6.71M

Net income from continuous operations

37.01%-4.57M

30.89%-4.94M

14.11%-6.86M

-4.80%-7.77M

-1.81%-7.25M

23.91%-7.14M

21.47%-7.99M

39.39%-7.41M

46.90%-7.12M

10.91%-9.39M

17.96%-10.18M

-30.60%-12.23M

-38.52%-13.42M

-7.82%-10.54M

-55.61%-12.40M

-82.54%-9.37M

-80.45%-9.69M

-99.00%-9.77M

-69.91%-7.97M

23.48%-5.13M

---5.37M

---4.91M

---4.69M

---6.71M

Net income attributable to controlling interests

37.01%-4.57M

30.89%-4.94M

14.11%-6.86M

-4.80%-7.77M

-1.81%-7.25M

23.91%-7.14M

21.47%-7.99M

39.39%-7.41M

46.90%-7.12M

10.91%-9.39M

17.96%-10.18M

-30.60%-12.23M

-38.52%-13.42M

-7.82%-10.54M

-55.61%-12.40M

-82.54%-9.37M

-80.45%-9.69M

-99.00%-9.77M

-66.22%-7.97M

32.98%-5.13M

---5.37M

---4.91M

---4.80M

---7.66M

Preferred share dividend

----

--0.00

-100.00%0.00

--0.00

--104.00K

--951.00K

Net income attributable to common shareholders

37.01%-4.57M

30.89%-4.94M

14.11%-6.86M

-4.80%-7.77M

-1.81%-7.25M

23.91%-7.14M

21.47%-7.99M

39.39%-7.41M

46.90%-7.12M

10.91%-9.39M

17.96%-10.18M

-30.60%-12.23M

-38.52%-13.42M

-7.82%-10.54M

-55.61%-12.40M

-82.54%-9.37M

-80.45%-9.69M

-99.00%-9.77M

-66.22%-7.97M

32.98%-5.13M

---5.37M

---4.91M

---4.80M

---7.66M

Basic earnings per share

-1156.02%-3.62

-1276.07%-3.91

14.60%-0.27

-4.04%-0.31

-3.29%-0.29

7.53%-0.28

3.23%-0.32

25.41%-0.30

36.06%-0.28

10.34%-0.31

18.54%-0.33

-30.13%-0.40

-37.93%-0.44

-7.42%-0.34

4.01%-0.40

-76.13%-0.31

-74.38%-0.32

-92.30%-0.32

-159.89%-0.42

32.98%-0.17

---0.18

---0.17

---0.16

---0.26

Diluted earnings per share

-1156.02%-3.62

-1276.07%-3.91

14.60%-0.27

-4.04%-0.31

-3.29%-0.29

7.53%-0.28

3.23%-0.32

25.41%-0.30

36.06%-0.28

10.34%-0.31

18.54%-0.33

-30.13%-0.40

-37.93%-0.44

-7.42%-0.34

4.01%-0.40

-76.13%-0.31

-74.38%-0.32

-92.30%-0.32

-159.89%-0.42

32.98%-0.17

---0.18

---0.17

---0.16

---0.26

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

